Comparison of efficacy and safety between standard-dose and modified-dose FOLFIRINOX as a first-line treatment of pancreatic cancer
Kang, Huapyong, Jo, Jung Hyun, Lee, Hee Seung, Chung, Moon Jae, Bang, Seungmin, Park, Seung Woo, Song, Si Young, Park, Jeong YoupVolume:
10
Journal:
World Journal of Gastrointestinal Oncology
DOI:
10.4251/wjgo.v10.i11.421
Date:
November, 2018
File:
PDF, 992 KB
2018